Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 60
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Participant, Investigator)|Primary Purpose: Treatment
Study ID Numbers: 2011-0289|HRPO Log Number A-15872|NCI-2010-02375|W81XWH-10-1-0699
Study First Received: June 27, 2013
Last Updated: October 6, 2016
Estimated Primary Completion Date: December 2018
Primary Outcome Measures:
1-Year Progression Free Survival
Sponsors and Collaborators:
M.D. Anderson Cancer Center|U.S. Army Medical Research and Materiel Command|Memorial Sloan Kettering Cancer Center|Sellas Life Sciences Group
Website Link: https://ClinicalTrials.gov/show/NCT01890980
